Sleep-Wake Disorders Questions & Answers

1. Zammit GK, Weiner J, Damato N, et al. Quality of life in people with insomnia. Sleep. 1999 May 1. 22 Suppl 2:S379-85. [QxMD MEDLINE Link].

2. Chen Q, Hayman LL, Shmerling RH, Bean JF, Leveille SG. Characteristics of Chronic Pain Associated with Sleep Difficulty in Older Adults: The Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly (MOBILIZE) Boston Study. J Am Geriatr Soc. 2011 Aug. 59(8):1385-92. [QxMD MEDLINE Link].

3. Yaffe K, Laffan AM, Harrison SL, et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA. 2011 Aug 10. 306(6):613-9. [QxMD MEDLINE Link].

4. Rajaratnam SM, Barger LK, Lockley SW, et al. Sleep disorders, health, and safety in police officers. JAMA. 2011 Dec 21. 306(23):2567-78. [QxMD MEDLINE Link].

5. J.Cheung C.M.Ruoff E.Mignot. Central Nervous System Hypersomnias J. Cheung, ... E. Mignot,. Mitchell G. Miglis. Sleep and Neurologic Disease,. 2017. 141-166.

6. Henri Korkalainen Juha Töyräs Sami Nikkonen Timo Leppänen. Mortality‐risk‐based apnea–hypopnea index thresholds for diagnostics of obstructive sleep apnea. J of Sleep Research. 2019.

7. Laura Palagini Celyne H. Bastien Donatella Marazziti Jason G. Ellis Dieter Riemann. The key role of insomnia and sleep loss in the dysregulation of multiple systems involved in mood disorders: A proposed model. J of Sleep Research. 2019.

8. Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009 May 20. 301(19):2005-15. [QxMD MEDLINE Link].

9. Wilson S, Anderson K, Baldwin D, Dijk D et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J Psychopharmacol. 2019. [QxMD MEDLINE Link].

10. Elie R, Ruther E, Farr I, Salinas E. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group. J Clin Psychiatry. 1999 Aug. 60(8):536-44. [QxMD MEDLINE Link].

11. Lockley S, Dressman M, Xiao C, Fisher D, Torres R, Lavedan C, et al. Tasimelteon treatment entrains the circadian clock and demonstrates a clinically meaningful benefit blind individuals with non-24-hour circadian rhythms. Presented at ENDO 2013: the Endocrinology Society 95th Annual Meeting. San Francisco. (SUN-134).

12. Lockley S, Dressman M, Xiao C, Licamele L, Polymeropoulos M. RESET study demonstrates that tasimelteon maintains entrainment of melatonin and cortisol in totally blind individuals with non-24-hour circadian rhythms. Presented at ENDO 2013: the Endocrinology Society 95th Annual Meeting. San Francisco. (SUN-137).

13. Belsomra (survorexant) prescribing information. [package insert]. Whitehouse Station, NJ 08889: August, 2014. Available at [Full Text].

Roy H Lubit, MD, PhD Private Practice

Roy H Lubit, MD, PhD is a member of the following medical societies: American Academy of Child and Adolescent Psychiatry

Disclosure: Nothing to disclose.

Curley L Bonds, II, MD Professor and Chair, Department of Psychiatry and Human Behavior, Charles Drew University of Medicine and Science; Health Sciences Clinical Professor, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, David Geffen School of Medicine

Curley L Bonds, II, MD is a member of the following medical societies: Academy of Psychosomatic Medicine, American Medical Association, National Medical Association, American Psychiatric Association

Disclosure: Nothing to disclose.

Michael A Lucia, MD, FAASM Owner/CEO, Pulmonary, Allergy and Sleep Medicine, Sierra Pulmonary and Sleep Consultants, LLC

Michael A Lucia, MD, FAASM is a member of the following medical societies: Nevada State Medical Association, American Academy of Sleep Medicine, American Association of Cardiovascular and Pulmonary Rehabilitation

Disclosure: Nothing to disclose.

Ana Hategan, MD, FRCPC Associate Clinical Professor, Department of Psychiatry and Behavioral Neurosciences, Division of Geriatric Psychiatry, McMaster University School of Medicine; Geriatric Psychiatrist, St Joseph's Health Care Hamilton, Canada

Ana Hategan, MD, FRCPC is a member of the following medical societies: Canadian Academy of Geriatric Psychiatry, Canadian Coalition for Seniors' Mental Health, Canadian Psychiatric Association, International Psychogeriatric Association, Ontario Medical Association, Royal College of Physicians and Surgeons of Canada

Disclosure: Book royalties and/or honoraria for articles from American Psychiatric Publishing, Springer, and Current Psychiatry.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Reference Salary Employment

• Print this section
• Print the entire contents of
• Print the entire contents of article